4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Levodopa: new trials by email Literature Review of Levodopa trials Research Report on Levodopa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study) Carbidopa/levodopa, Placebo - Depression, Cognitive Impairment | Phase 4 | Terminated | New York State Psychiatric Institute | 5 | 2021-02-10 | 2023-05-22 |
| L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults L-DOPA, Placebo Oral Tablet - Major Depressive Disorder, Dysthymia | Phase 4 | Terminated | New York State Psychiatric Institute | 51 | 2019-01-09 | 2023-05-22 |
| Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off Carbidopa/levodopa/entacapone, Immediate release carbidopa/levodopa - Parkinson's Disease | Phase 4 | Terminated | Novartis | 14 | 2008-03-01 | 2011-02-18 |
| Neuromodulation and Language Acquisition (Project Stage Ia) levodopa, rivastigmine, pergolid - Healthy | Phase 4 | Terminated | University Hospital Muenster | 100 | 2004-03-01 | 2010-01-27 |
Depression (2) · Cognitive Dysfunction (1) · Depressive Disorder, Major (1) · Dysthymic Disorder (1) · Parkinson Disease (1)
New York State Psychiatric Institute (2) · Novartis (1) · University Hospital Muenster (1)
United States (3) · Germany (1)
Bret R Rutherford, MD (1) · Bret Rutherford, MD (1) · Caterina Breitenstein, PhD (1) · Stefan Knecht, MD (1)
R01MH123660 (1), R33MH110029 (1)